Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Stoke Therapeutics Inc. (STOK)

34.33   0.84 (2.51%) 10-01 15:22
Open: 33.64 Pre. Close: 33.49
High: 35 Low: 33.64
Volume: 85,256 Market Cap: 1,141M
Stoke Therapeutics, Inc. is a biotechnology company, which engages in the research and development of treatments for genetic diseases. The company is headquartered in Bedford, Massachusetts and currently employs 44 full-time employees. The firm develops antisense oligonucleotide medicines that target ribo-nucleic acid (RNA) splicing to increase gene expression for the treatment of severe genetic diseases. The company uses targeted augmentation of nuclear gene output (TANGO) to effect targeted enhancement of gene expression. The company provides TANGO, which is a precision medicine platform for treating a category of genetic diseases, such as autosomal dominant haploinsufficiency. TANGO is designed to address protein deficiency by upregulating target protein expression.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 34.335 - 34.566 34.566 - 34.757
Low: 32.466 - 32.686 32.686 - 32.869
Close: 33.163 - 33.525 33.525 - 33.826

Technical analysis

as of: 2020-10-01 3:10:01 PM
Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 44.24     One year: 51.68
Support: Support1: 31.47    Support2: 27.50
Resistance: Resistance1: 37.88    Resistance2: 44.24
Pivot: 34.26
Moving Average: MA(5): 34.49     MA(20): 33.19
MA(100): 27.44     MA(250): 25.65
MACD: MACD(12,26): 1.43     Signal(9): 1.58
Stochastic oscillator: %K(14,3): 47.21     %D(3): 55.45
RSI: RSI(14): 59.23
52-week: High: 37.88  Low: 15.82  Change(%): 59.9
Average Vol(K): 3-Month: 10651  10-Days: 12360

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
STOK has closed below upper band by 39.1%. Bollinger Bands are 13.6% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Tue, 29 Sep 2020
ARNA: 4 Biotech Stocks Showing Strength During the Market Selloff in September -

Tue, 29 Sep 2020
Benzinga's Top Upgrades, Downgrades For September 29, 2020 - Benzinga

Tue, 15 Sep 2020
Stoke Therapeutics (NASDAQ:STOK) Is In A Good Position To Deliver On Growth Plans - Yahoo Finance

Tue, 15 Sep 2020
The Daily Biotech Pulse: Marinus Epilepsy Study Meets Goal, Novavax Reaches Vaccine Manufacturing Deal, Outset Medical's IPO - Yahoo Finance

Wed, 09 Sep 2020
Stoke Therapeutics to Present at Cantor Virtual Global Healthcare Conference - Yahoo Finance

Fri, 24 Jul 2020
Stoke Therapeutics Inc (NASDAQ:STOK) Announces The Publication Of Data Regarding Its Proprietary Approach To Treating Severe Genetic Diseases In The Journal Nature Communications - BP Journal

Financial Analysis

Growth n/a
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability n/a
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency n/a
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Underperform
Return on Equity: Neutral Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 33
Shares Float (M) 8
% Held by Insiders 1.28
% Held by Institutions 103.55
Shares Short (K) 2,770
Shares Short P. Month (K) 2,580

Stock Financials

EPS -2.660
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) 7.140
Profit Margin
Operating Margin
Return on Assets (ttm) -12.5
Return on Equity (ttm) -19.2
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.) -1.353
Qtrly Earnings Growth
Operating Cash Flow (M) -39
Levered Free Cash Flow (M) -27

Stock Valuations

PE Ratio -13.09
PEG Ratio
Price to Book value 4.88
Price to Sales
Price to Cash Flow -29.92

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.